Novo Nordisk adds 69.2 billion kroner to its market value on Monday, after the stock has risen by 5.3 percent. (Archive photo). Photo: Tom Little/Reuters
Novo shares up over 5% after fight against generics
On Monday, Novo Nordisk’s stock rose by 5.3%, making it the highest riser in Denmark’s C25 index. The increase added DKK 69.2 billion to its market value. This follows the announcement that Hims & Hers, an American online pharmacy, will not sell a copy of Novo Nordisk’s Wegovy pill. Novo Nordisk...
Get full access to Danish News in English
Gain exclusive access to daily news updates in English pertaining to Denmark with a Ritzau News subscription.
Already a subscriber?